Wang, C J <br/><br/>
The combinational therapy of trastuzumab and cetuximab inhibits tumor growth in a patient-derived tumor xenograft model of gastric cancer.  [electronic resource] 

 -  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico  May 2016 
 - 507-14 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1699-3055 
<br/><br/><label>Standard No.: </label>10.1007/s12094-015-1397-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Cell Cycle--drug effects<br/>Cetuximab--administration & dosage<br/>Flow Cytometry<br/>Humans<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Neoplasm Staging<br/>Prognosis<br/>Stomach Neoplasms--pathology<br/>Trastuzumab--administration & dosage<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays